Peptide Therapeutics 2.0

Beatriz G de la Torre; Fernando Albericio

doi:10.3390/molecules25102293

Peptide Therapeutics 2.0

Molecules. 2020 May 13;25(10):2293. doi: 10.3390/molecules25102293.

Authors

Beatriz G de la Torre¹, Fernando Albericio^{2

3

4}

Affiliations

¹ KwaZulu-Natal Research Innovation and Sequencing Platform (KRISP), School of Laboratory Medicine and Medical Sciences, College of Health Sciences, University of KwaZulu-Natal, Durban 4041, South Africa.
² Peptide Science Laboratory, School of Chemistry and Physics, University of KwaZulu-Natal, Westville, Durban 4000, South Africa.
³ CIBER-BBN, Networking Centre on Bioengineering, Biomaterials and Nanomedicine, Institute for Advanced Chemistry of Catalonia (IQAC-CSIC), 08034 Barcelona, Spain.
⁴ Department of Organic Chemistry, University of Barcelona, Martí i Franqués 1-11, 08028 Barcelona, Spain.

Abstract

In recent years, the peptide drug discovery field has shown a high level of dynamism, with hundreds of academic groups working on this topic, the creation of new peptide-focused companies, and the consolidation of peptide business by so-called big pharma [...].

Publication types

Editorial

MeSH terms

Drug Discovery*
Drug Industry*
Humans
Peptides* / chemical synthesis
Peptides* / chemistry
Peptides* / therapeutic use

Substances

Peptides